URTICARIA CHRONIC

Clinical trials for URTICARIA CHRONIC explained in plain language.

Never miss a new study

Get alerted when new URTICARIA CHRONIC trials appear

Sign up with your email to follow new studies for URTICARIA CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hives drug shows promise in early trial

Symptom relief Recruiting now

This study tests a new medication called ARS-2 for people with chronic spontaneous urticaria (long-term hives). It aims to see if ARS-2 can quickly reduce itching and hives during flare-ups. The trial involves 42 adults who will receive either ARS-2 or a placebo during separate f…

Matched conditions: URTICARIA CHRONIC

Phase: PHASE2 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 07:53 UTC

URTICARIA CHRONIC

Get alerted when new URTICARIA CHRONIC trials appear

New hives drug shows promise in early trial